Overview

Safety and Pharmacokinetics of Vasopressin in Healthy Volunteers

Status:
Completed
Trial end date:
2021-04-11
Target enrollment:
Participant gender:
Summary
Open-label Phase I pharmacokinetic (PK) study of Vasostrict® (vasopressin injection, USP) in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Endo Pharmaceuticals
Treatments:
Arginine Vasopressin
Vasopressins